IsoRay (ISR +1.7%) inks an agreement with
MIM Software for, what it says, is a novel one-stop-provides-all
program to treat head and neck cancer. The new offering bundles MIM’s
software technology and Isoray’s Cesium Blu, also known as Cesium-131,
brachytherapy expanding treatment options and access for both doctors
and patients.
https://seekingalpha.com/news/3538596-isoray-to-offer-total-solution-in-head-and-neck-cancer
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.